• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

cIMPACT-NOW更新6:关于未来中枢神经系统肿瘤分类和分级的cIMPACT-乌得勒支会议的新实体和诊断原则建议。

cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

作者信息

Louis David N, Wesseling Pieter, Aldape Kenneth, Brat Daniel J, Capper David, Cree Ian A, Eberhart Charles, Figarella-Branger Dominique, Fouladi Maryam, Fuller Gregory N, Giannini Caterina, Haberler Christine, Hawkins Cynthia, Komori Takashi, Kros Johan M, Ng H K, Orr Brent A, Park Sung-Hye, Paulus Werner, Perry Arie, Pietsch Torsten, Reifenberger Guido, Rosenblum Marc, Rous Brian, Sahm Felix, Sarkar Chitra, Solomon David A, Tabori Uri, van den Bent Martin J, von Deimling Andreas, Weller Michael, White Valerie A, Ellison David W

机构信息

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.

出版信息

Brain Pathol. 2020 Jul;30(4):844-856. doi: 10.1111/bpa.12832. Epub 2020 Apr 19.

DOI:10.1111/bpa.12832
PMID:32307792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8018152/
Abstract

cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) was established to evaluate and make practical recommendations on recent advances in the field of CNS tumor classification, particularly in light of the rapid progress in molecular insights into these neoplasms. For Round 2 of its deliberations, cIMPACT-NOW Working Committee 3 was reconstituted and convened in Utrecht, The Netherlands, for a meeting designed to review putative new CNS tumor types in advance of any future World Health Organization meeting on CNS tumor classification. In preparatory activities for the meeting and at the actual meeting, a list of possible entities was assembled and each type and subtype debated. Working Committee 3 recommended that a substantial number of newly recognized types and subtypes should be considered for inclusion in future CNS tumor classifications. In addition, the group endorsed a number of principles-relating to classification categories, approaches to classification, nomenclature, and grading-that the group hopes will also inform the future classification of CNS neoplasms.

摘要

cIMPACT-NOW(中枢神经系统肿瘤分类分子与实践方法信息联盟)的成立是为了评估中枢神经系统肿瘤分类领域的最新进展并提出实用建议,特别是鉴于对这些肿瘤分子认识的快速进展。在其第二轮审议中,cIMPACT-NOW第3工作委员会进行了重组,并在荷兰乌得勒支召开会议,旨在在世卫组织未来任何关于中枢神经系统肿瘤分类的会议之前,对假定的新中枢神经系统肿瘤类型进行审查。在会议的筹备活动以及实际会议期间,收集了一份可能的实体清单,并对每种类型和亚型进行了讨论。第3工作委员会建议,未来的中枢神经系统肿瘤分类应考虑纳入大量新确认的类型和亚型。此外,该小组认可了一些与分类类别、分类方法、命名法和分级相关的原则,希望这些原则也能为未来中枢神经系统肿瘤的分类提供参考。

相似文献

1
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.cIMPACT-NOW更新6:关于未来中枢神经系统肿瘤分类和分级的cIMPACT-乌得勒支会议的新实体和诊断原则建议。
Brain Pathol. 2020 Jul;30(4):844-856. doi: 10.1111/bpa.12832. Epub 2020 Apr 19.
2
What Every Neuropathologist Needs to Know: Update on cIMPACT-NOW.神经病理学家须知:cIMPACT-NOW 更新。
J Neuropathol Exp Neurol. 2019 Apr 1;78(4):294-296. doi: 10.1093/jnen/nlz012.
3
Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.弥漫性胶质瘤:2016 年世界卫生组织中枢神经系统肿瘤分类之后的进展。
Int J Clin Oncol. 2020 Jun;25(6):997-1003. doi: 10.1007/s10147-020-01695-w. Epub 2020 May 28.
4
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates.cIMPACT-NOW:一轮更新诊断要点的实用总结。
Brain Pathol. 2019 Jul;29(4):469-472. doi: 10.1111/bpa.12732. Epub 2019 May 22.
5
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.cIMPACT-NOW更新8:脑膜瘤分子风险参数的澄清及世界卫生组织分级建议
Neuro Oncol. 2025 Feb 10;27(2):319-330. doi: 10.1093/neuonc/noae170.
6
cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification.cIMPACT-NOW(中枢神经系统肿瘤分类分子与实践方法信息联盟):推进神经系统肿瘤分类的一项新举措。
Brain Pathol. 2017 Nov;27(6):851-852. doi: 10.1111/bpa.12457. Epub 2016 Dec 20.
7
[The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].[《2021年世界卫生组织中枢神经系统肿瘤分类》第5版:简要回顾]
Brain Nerve. 2022 Jun;74(6):803-809. doi: 10.11477/mf.1416202124.
8
Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.2021 年世界卫生组织中枢神经系统肿瘤分类的重大变化。
Radiographics. 2022 Sep-Oct;42(5):1474-1493. doi: 10.1148/rg.210236. Epub 2022 Jul 8.
9
World Health Organization Classification of Tumors of the Central Nervous System 5 Edition (WHO CNS5): What's new?世界卫生组织中枢神经系统肿瘤分类第五版(WHO CNS5):有哪些新变化?
Indian J Pathol Microbiol. 2022 May;65(Supplement):S5-S13. doi: 10.4103/ijpm.ijpm_48_22.
10
The cIMPACT-NOW updates and their significance to current neuro-oncology practice.cIMPACT-NOW更新及其对当前神经肿瘤学实践的意义。
Neurooncol Pract. 2020 Aug 29;8(1):4-10. doi: 10.1093/nop/npaa055. eCollection 2021 Feb.

引用本文的文献

1
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.异柠檬酸脱氢酶(IDH)突变型星形细胞瘤的进化轨迹确定了与细胞周期相关的分子分级标志物。
Nat Cancer. 2025 Aug 19. doi: 10.1038/s43018-025-01023-z.
2
CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.伴有BCOR/BCORL1融合的中枢神经系统肿瘤:一种罕见的肿瘤实体。
Int J Mol Sci. 2025 Jul 14;26(14):6729. doi: 10.3390/ijms26146729.
3
Surgical outcomes in diffuse leptomeningeal glioneuronal tumours: a systematic review and individual patient data meta-analysis.弥漫性软脑膜神经胶质瘤的手术结果:一项系统评价和个体患者数据荟萃分析
Neurosurg Rev. 2025 Jul 19;48(1):573. doi: 10.1007/s10143-025-03732-6.
4
Can diffusion-based generated magnetic resonance images predict glioma methylation accurately?基于扩散生成的磁共振图像能否准确预测胶质瘤甲基化?
Quant Imaging Med Surg. 2025 Jun 6;15(6):5647-5659. doi: 10.21037/qims-24-1688. Epub 2025 May 21.
5
Cerebrospinal Fluid-Derived Genomic Alterations Tracking Glioma.脑脊液衍生基因组改变追踪胶质瘤
J Mol Neurosci. 2025 Jun 20;75(3):79. doi: 10.1007/s12031-025-02361-4.
6
Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms.在多个检测平台上评估胶质瘤中CDKN2A基因的纯合和杂合缺失。
BMC Cancer. 2025 Jun 5;25(1):1007. doi: 10.1186/s12885-025-14266-x.
7
Updating TCGA glioma classification through integration of molecular data following the latest WHO guidelines.依据世界卫生组织最新指南,通过整合分子数据更新癌症基因组图谱(TCGA)胶质瘤分类。
Sci Data. 2025 Jun 4;12(1):935. doi: 10.1038/s41597-025-05117-2.
8
Construction and validation of a prognostic nomogram model integrating machine learning-pathomics and clinical features in IDH-wildtype glioblastoma.整合机器学习-病理组学和临床特征的IDH野生型胶质母细胞瘤预后列线图模型的构建与验证
J Transl Med. 2025 Jun 3;23(1):618. doi: 10.1186/s12967-025-06482-7.
9
Poor diagnostic value of isocitrate dehydrogenase 1 R132H immunohistochemistry for determination of isocitrate dehydrogenase 1 status in patients with glioblastoma.异柠檬酸脱氢酶1 R132H免疫组化在胶质母细胞瘤患者中对确定异柠檬酸脱氢酶1状态的诊断价值较低。
Surg Neurol Int. 2025 Apr 18;16:140. doi: 10.25259/SNI_881_2024. eCollection 2025.
10
Exploring neonatal brain tumors: a narrative review about epidemiology, classification, and management.探索新生儿脑肿瘤:关于流行病学、分类和管理的叙述性综述。
Ann Med Surg (Lond). 2025 Apr 2;87(5):2838-2846. doi: 10.1097/MS9.0000000000003229. eCollection 2025 May.

本文引用的文献

1
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.cIMPACT-NOW更新5:IDH突变型星形细胞瘤的推荐分级标准和术语
Acta Neuropathol. 2020 Mar;139(3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29.
2
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.被诊断为小脑胶质母细胞瘤的肿瘤包含不同的分子实体。
Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478-019-0801-8.
3
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.弥漫性星形细胞瘤,IDH1/2 野生型,具有胶质母细胞瘤的分子特征,WHO 分级 IV:对 cIMPACT-NOW 标准的确认。
Neuro Oncol. 2020 Apr 15;22(4):515-523. doi: 10.1093/neuonc/noz200.
4
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.黏液样软骨样神经胶质肿瘤,PDGFRA p.K385 突变:临床、影像学和组织病理学特征。
Brain Pathol. 2020 May;30(3):479-494. doi: 10.1111/bpa.12797. Epub 2019 Nov 6.
5
Polymorphous Low-Grade Neuroepithelial Tumor of the Young: A Case Report with Genomic Findings.年轻患者多形性低级别神经上皮肿瘤:伴有基因组发现的病例报告。
World Neurosurg. 2019 Dec;132:347-355. doi: 10.1016/j.wneu.2019.08.221. Epub 2019 Sep 11.
6
MYCN amplification drives an aggressive form of spinal ependymoma.MYCN 扩增驱动侵袭性脊髓室管膜瘤。
Acta Neuropathol. 2019 Dec;138(6):1075-1089. doi: 10.1007/s00401-019-02056-2. Epub 2019 Aug 14.
7
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.MYCN 扩增的脊髓室管膜瘤表现出侵袭性临床行为。
J Neuropathol Exp Neurol. 2019 Sep 1;78(9):791-797. doi: 10.1093/jnen/nlz064.
8
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting.中枢神经系统肿瘤报告用数据集:国际癌症报告协作组的建议。
Arch Pathol Lab Med. 2020 Feb;144(2):196-206. doi: 10.5858/arpa.2018-0565-OA. Epub 2019 Jun 20.
9
MN1 rearrangement in astroblastoma: study of eight cases and review of literature.星形母细胞瘤中的 MN1 重排:8 例病例研究及文献复习。
Brain Tumor Pathol. 2019 Jul;36(3):112-120. doi: 10.1007/s10014-019-00346-x. Epub 2019 May 20.
10
High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.伴有 BCOR 外显子 15 内串联重复的高级别神经上皮肿瘤:全面的临床、影像学、病理学和基因组分析。
Brain Pathol. 2020 Jan;30(1):46-62. doi: 10.1111/bpa.12747. Epub 2019 Jun 10.